Medicine and Health Sciences Commons^™

Ketamine Use In Refractory Depression, Mckenzie K. Kemmet

Physician Assistant Scholarly Project Papers

Despite pharmacological advancements, depression continues to be considered the third leading cause of disability in the world. Although depressive symptoms may decrease within a few weeks after beginning typical antidepressants, there are still about one-third of individuals that fail to respond and do not achieve recovery. The symptoms not resolved by antidepressant therapy ultimately leads to decreased quality of life, decreased productiveness of the individual, increased hospitalizations, higher health care costs, and increased rates of suicide. As a result, the clinical use of ketamine in refractory depression is increasing because of the antidepressant properties found in a multitude of studies. …